A logo

Agilent Technologies (A) EBITDA

annual EBITDA:

$1.87B+$169.00M(+9.91%)
October 31, 2024

Summary

  • As of today (May 29, 2025), A annual EBITDA is $1.87 billion, with the most recent change of +$169.00 million (+9.91%) on October 31, 2024.
  • During the last 3 years, A annual EBITDA has risen by +$112.00 million (+6.36%).
  • A annual EBITDA is now -1.63% below its all-time high of $1.91 billion, reached on October 31, 2022.

Performance

1-year change

+9.91%

3-year change

+6.36%

5-year change

+52.23%

15-year change

+71.3%

A EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

96.19%
A annual EBITDA is higher than 96.19% of companies in Healthcare sector

Range

All-time high

$1.91B
A annual EBITDA is currently -1.63% below its historical high of $1.91 billion

3-year low

$1.71B
A annual EBITDA is currently +9.91% above its 3-year low

Earnings dates

Last annual earnings report date

Oct 31, 2024
A previous annual earnings announcement was published on Oct 31, 2024

Next annual earnings report date

N/A
A next annual earnings announcement has not yet been scheduled

OtherAincome statement metrics

Annual revenue

$6.51B
A annual revenue is $6.51 billion

annual net income

$1.29B
A annual net profit is $1.29 billion

annual EBIT

$1.62B
A annual earnings before interest & taxes is $1.62 billion

Annual EPS

$4.43
A annual earnings per share is $4.43

quarterly EBITDA:

$467.00M-$35.00M(-6.97%)
January 31, 2025

Summary

  • As of today (May 29, 2025), A quarterly EBITDA is $467.00 million, with the most recent change of -$35.00 million (-6.97%) on January 31, 2025.
  • Over the past year, A quarterly EBITDA has dropped by -$20.00 million (-4.11%).
  • A quarterly EBITDA is now -77.62% below its all-time high of $2.09 billion, reached on July 31, 1999.

Performance

3-month change

-6.97%

1-year change

-4.11%

3-year change

+10.66%

5-year change

+46.86%

A quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

95.29%
A quarterly EBITDA is higher than 95.29% of companies in Healthcare sector

Range

All-time high

$2.09B
A quarterly EBITDA is currently -77.62% below its historical high of $2.09 billion

3-year low

$227.00M
A quarterly EBITDA is currently +105.73% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jan 31, 2025
A previous earnings announcement was published on Jan 31, 2025

Next quarterly earnings report date

N/A
A next earnings announcement has not yet been scheduled

OtherAincome statement metrics

Quarterly revenue

$1.68B
A quarterly revenue is $1.68 billion

quarterly net income

$318.00M
A quarterly net profit is $318.00 million

quarterly EBIT

$395.00M
A quarterly earnings before interest & taxes is $395.00 million

Quarterly EPS

$1.11
A quarterly earnings per share is $1.11

TTM EBITDA:

$1.85B-$20.00M(-1.07%)
January 31, 2025

Summary

  • As of today (May 29, 2025), A TTM EBITDA is $1.85 billion, with the most recent change of -$20.00 million (-1.07%) on January 31, 2025.
  • Over the past year, A TTM EBITDA has increased by +$164.00 million (+9.70%).
  • A TTM EBITDA is now -68.49% below its all-time high of $5.88 billion, reached on July 31, 1999.

Performance

3-month change

-1.07%

1-year change

+9.7%

3-year change

+4.33%

5-year change

+60.1%

A TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

95.8%
A TTM EBITDA is higher than 95.8% of companies in Healthcare sector

Range

All-time high

$5.88B
A TTM EBITDA is currently -68.49% below its historical high of $5.88 billion

3-year low

$1.68B
A TTM EBITDA is currently +10.69% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jan 31, 2025
A previous earnings announcement was published on Jan 31, 2025

Next quarterly earnings report date

N/A
A next earnings announcement has not yet been scheduled

OtherAincome statement metrics

TTM revenue

$6.53B
A TTM revenue is $6.53 billion

TTM net income

$1.26B
A TTM net profit is $1.26 billion

TTM EBIT

$1.59B
A TTM earnings before interest & taxes is $1.59 billion

TTM EPS

$4.35
A TTM earnings per share is $4.35

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$1.87B
A annual EBITDA is $1.87 billion

annual net income

$1.29B
A annual net profit is $1.29 billion

annual interest expense

$96.00M
A annual interest expense is $96.00 million

annual income tax

$232.00M
A annual income tax is $232.00 million

annual D&A

$257.00M
A annual depreciation & amortization is $257.00 million

A EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.9%-4.1%+9.7%
3 y3 years+6.4%+10.7%+4.3%
5 y5 years+52.2%+46.9%+60.1%

A EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1.6%+9.9%-15.3%+105.7%-8.3%+10.7%
5 y5-year-1.6%+52.6%-15.6%+115.2%-8.3%+60.1%
alltimeall time-1.6%+314.9%-77.6%+108.5%-68.5%+140.3%

A EBITDA History

DateAnnualQuarterlyTTM
Jan 2025
-
$467.00M(-7.0%)
$1.85B(-1.1%)
Oct 2024
$1.87B(+9.9%)
$502.00M(+17.3%)
$1.87B(-0.1%)
Jul 2024
-
$428.00M(-6.3%)
$1.88B(+12.0%)
Apr 2024
-
$457.00M(-6.2%)
$1.68B(-0.9%)
Jan 2024
-
$487.00M(-3.4%)
$1.69B(-0.9%)
Oct 2023
$1.71B(-10.5%)
$504.00M(+122.0%)
$1.71B(-2.7%)
Jul 2023
-
$227.00M(-51.9%)
$1.75B(-13.3%)
Apr 2023
-
$472.00M(-6.0%)
$2.02B(+1.8%)
Jan 2023
-
$502.00M(-8.9%)
$1.99B(+4.2%)
Oct 2022
$1.91B(+8.1%)
$551.00M(+11.1%)
$1.91B(-0.1%)
Jul 2022
-
$496.00M(+13.8%)
$1.91B(+3.5%)
Apr 2022
-
$436.00M(+3.3%)
$1.84B(+3.7%)
Jan 2022
-
$422.00M(-23.7%)
$1.78B(+0.9%)
Oct 2021
$1.76B(+43.5%)
$553.00M(+28.0%)
$1.76B(+11.0%)
Jul 2021
-
$432.00M(+16.8%)
$1.59B(+8.0%)
Apr 2021
-
$370.00M(-9.1%)
$1.47B(+11.6%)
Jan 2021
-
$407.00M(+7.7%)
$1.32B(+7.2%)
Oct 2020
$1.23B(-0.2%)
$378.00M(+20.0%)
$1.23B(+4.2%)
Jul 2020
-
$315.00M(+45.2%)
$1.18B(+1.7%)
Apr 2020
-
$217.00M(-31.8%)
$1.16B(-5.8%)
Jan 2020
-
$318.00M(-3.0%)
$1.23B(-0.2%)
Oct 2019
$1.23B(0.0%)
$328.00M(+11.2%)
$1.23B(+0.8%)
Jul 2019
-
$295.00M(+2.4%)
$1.22B(-1.5%)
Apr 2019
-
$288.00M(-10.0%)
$1.24B(-0.6%)
Jan 2019
-
$320.00M(+0.6%)
$1.25B(+1.3%)
Oct 2018
$1.23B(+12.5%)
$318.00M(+1.6%)
$1.23B(+1.7%)
Jul 2018
-
$313.00M(+5.7%)
$1.21B(+4.3%)
Apr 2018
-
$296.00M(-2.6%)
$1.16B(+2.7%)
Jan 2018
-
$304.00M(+2.0%)
$1.13B(+3.3%)
Oct 2017
$1.09B(+26.9%)
$298.00M(+13.3%)
$1.09B(+7.0%)
Jul 2017
-
$263.00M(-0.8%)
$1.02B(+5.4%)
Apr 2017
-
$265.00M(-1.1%)
$970.00M(+7.3%)
Jan 2017
-
$268.00M(+18.6%)
$904.00M(+4.9%)
Oct 2016
$862.00M(+7.9%)
$226.00M(+7.1%)
$862.00M(+0.8%)
Jul 2016
-
$211.00M(+6.0%)
$855.00M(+0.5%)
Apr 2016
-
$199.00M(-11.9%)
$851.00M(+2.8%)
Jan 2016
-
$226.00M(+3.2%)
$828.00M(+3.6%)
Oct 2015
$799.00M(+10.5%)
$219.00M(+5.8%)
$799.00M(+18.5%)
Jul 2015
-
$207.00M(+17.6%)
$674.00M(-0.6%)
Apr 2015
-
$176.00M(-10.7%)
$678.00M(-2.9%)
Jan 2015
-
$197.00M(+109.6%)
$698.00M(-3.5%)
Oct 2014
$723.00M(-6.3%)
$94.00M(-55.5%)
$723.00M(+63.6%)
Jul 2014
-
$211.00M(+7.7%)
$442.00M(-21.2%)
Apr 2014
-
$196.00M(-11.7%)
$561.00M(-17.5%)
Jan 2014
-
$222.00M(-218.7%)
$680.00M(-11.9%)
Oct 2013
$772.00M(-46.6%)
-$187.00M(-156.7%)
$772.00M(-42.2%)
Jul 2013
-
$330.00M(+4.8%)
$1.33B(-1.2%)
Apr 2013
-
$315.00M(+0.3%)
$1.35B(-4.5%)
Jan 2013
-
$314.00M(-16.5%)
$1.42B(-2.1%)
Oct 2012
$1.45B(+5.4%)
$376.00M(+8.7%)
$1.45B(-0.2%)
Jul 2012
-
$346.00M(-8.7%)
$1.45B(-1.2%)
Apr 2012
-
$379.00M(+10.2%)
$1.47B(+2.4%)
Jan 2012
-
$344.00M(-9.2%)
$1.43B(+4.4%)
DateAnnualQuarterlyTTM
Oct 2011
$1.37B(+38.5%)
$379.00M(+4.1%)
$1.37B(+3.2%)
Jul 2011
-
$364.00M(+5.8%)
$1.33B(+4.2%)
Apr 2011
-
$344.00M(+21.1%)
$1.28B(+13.0%)
Jan 2011
-
$284.00M(-15.7%)
$1.13B(+14.0%)
Oct 2010
$990.00M(+285.2%)
$337.00M(+8.4%)
$990.00M(+24.8%)
Jul 2010
-
$311.00M(+57.9%)
$793.00M(+57.7%)
Apr 2010
-
$197.00M(+35.9%)
$503.00M(+61.7%)
Jan 2010
-
$145.00M(+3.6%)
$311.00M(+21.0%)
Oct 2009
$257.00M(-77.4%)
$140.00M(+566.7%)
$257.00M(-43.0%)
Jul 2009
-
$21.00M(+320.0%)
$451.00M(-38.5%)
Apr 2009
-
$5.00M(-94.5%)
$733.00M(-27.0%)
Jan 2009
-
$91.00M(-72.8%)
$1.00B(-8.4%)
Oct 2008
$1.14B(+47.0%)
$334.00M(+10.2%)
$1.10B(+9.6%)
Jul 2008
-
$303.00M(+9.8%)
$1.00B(+9.3%)
Apr 2008
-
$276.00M(+50.8%)
$915.00M(+12.0%)
Jan 2008
-
$183.00M(-23.1%)
$817.00M(+5.4%)
Oct 2007
$775.00M(+22.2%)
$238.00M(+9.2%)
$775.00M(+7.3%)
Jul 2007
-
$218.00M(+22.5%)
$722.00M(-1.8%)
Apr 2007
-
$178.00M(+26.2%)
$735.00M(+14.3%)
Jan 2007
-
$141.00M(-23.8%)
$643.00M(+11.2%)
Oct 2006
$634.00M(+60.1%)
$185.00M(-19.9%)
$578.00M(+8.4%)
Jul 2006
-
$231.00M(+168.6%)
$533.00M(+38.1%)
Apr 2006
-
$86.00M(+13.2%)
$386.00M(0.0%)
Jan 2006
-
$76.00M(-45.7%)
$386.00M(-2.5%)
Oct 2005
$396.00M(+44.0%)
$140.00M(+66.7%)
$396.00M(+1700.0%)
Jul 2005
-
$84.00M(-2.3%)
$22.00M(-80.9%)
Apr 2005
-
$86.00M(0.0%)
$115.00M(-46.5%)
Jan 2005
-
$86.00M(-136.8%)
$215.00M(-25.6%)
Oct 2004
$275.00M(-176.8%)
-$234.00M(-232.2%)
$289.00M(-57.1%)
Jul 2004
-
$177.00M(-4.8%)
$673.00M(+69.5%)
Apr 2004
-
$186.00M(+16.3%)
$397.00M(-1754.2%)
Jan 2004
-
$160.00M(+6.7%)
-$24.00M(-93.3%)
Oct 2003
-$358.00M(-58.9%)
$150.00M(-251.5%)
-$358.00M(-49.4%)
Jul 2003
-
-$99.00M(-57.9%)
-$708.00M(-17.5%)
Apr 2003
-
-$235.00M(+35.1%)
-$858.00M(+6.8%)
Jan 2003
-
-$174.00M(-13.0%)
-$803.00M(-7.9%)
Oct 2002
-$872.00M(+1881.8%)
-$200.00M(-19.7%)
-$872.00M(-23.9%)
Jul 2002
-
-$249.00M(+38.3%)
-$1.15B(+12.7%)
Apr 2002
-
-$180.00M(-25.9%)
-$1.02B(+41.3%)
Jan 2002
-
-$243.00M(-48.7%)
-$720.00M(+1120.3%)
Oct 2001
-$44.00M(-103.2%)
-$474.00M(+295.0%)
-$59.00M(-105.9%)
Jul 2001
-
-$120.00M(-202.6%)
$1.00B(-30.8%)
Apr 2001
-
$117.00M(-72.0%)
$1.45B(-9.7%)
Jan 2001
-
$418.00M(-28.7%)
$1.60B(+10.4%)
Oct 2000
$1.38B(+60.6%)
$586.00M(+80.3%)
$1.45B(-131.6%)
Jul 2000
-
$325.00M(+19.0%)
-$4.60B(+62.2%)
Apr 2000
-
$273.00M(+2.2%)
-$2.83B(+158.3%)
Jan 2000
-
$267.00M(-104.9%)
-$1.10B(-360.0%)
Oct 1999
$862.00M(-6.2%)
-$5.46B(-361.7%)
$422.00M(-92.8%)
Jul 1999
-
$2.09B(+3.8%)
$5.88B(+55.0%)
Apr 1999
-
$2.01B(+12.5%)
$3.80B(+112.5%)
Jan 1999
-
$1.79B
$1.79B
Oct 1998
$919.00M
-
-

FAQ

  • What is Agilent Technologies annual EBITDA?
  • What is the all time high annual EBITDA for Agilent Technologies?
  • What is Agilent Technologies annual EBITDA year-on-year change?
  • What is Agilent Technologies quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Agilent Technologies?
  • What is Agilent Technologies quarterly EBITDA year-on-year change?
  • What is Agilent Technologies TTM EBITDA?
  • What is the all time high TTM EBITDA for Agilent Technologies?
  • What is Agilent Technologies TTM EBITDA year-on-year change?

What is Agilent Technologies annual EBITDA?

The current annual EBITDA of A is $1.87B

What is the all time high annual EBITDA for Agilent Technologies?

Agilent Technologies all-time high annual EBITDA is $1.91B

What is Agilent Technologies annual EBITDA year-on-year change?

Over the past year, A annual EBITDA has changed by +$169.00M (+9.91%)

What is Agilent Technologies quarterly EBITDA?

The current quarterly EBITDA of A is $467.00M

What is the all time high quarterly EBITDA for Agilent Technologies?

Agilent Technologies all-time high quarterly EBITDA is $2.09B

What is Agilent Technologies quarterly EBITDA year-on-year change?

Over the past year, A quarterly EBITDA has changed by -$20.00M (-4.11%)

What is Agilent Technologies TTM EBITDA?

The current TTM EBITDA of A is $1.85B

What is the all time high TTM EBITDA for Agilent Technologies?

Agilent Technologies all-time high TTM EBITDA is $5.88B

What is Agilent Technologies TTM EBITDA year-on-year change?

Over the past year, A TTM EBITDA has changed by +$164.00M (+9.70%)
On this page